Isis Pharmaceuticals News
Most Popular Isis Pharmaceuticals Story
Genzyme: Phase III mipomersen a success
Researchers for Genzyme and Isis Pharmaceuticals say that a late-stage clinical trial turned up positive data for their cholesterol drug mipomersen. Patients taking the drug over a 26-week period Read more...
Latest Headlines
- January 4, 2012
- November 22, 2011
- April 5, 2011
- February 4, 2011
- September 1, 2010
- August 4, 2010
- March 31, 2010
- February 10, 2010
- November 17, 2009
- November 12, 2009
- May 20, 2009
- March 4, 2009
- January 14, 2009
- December 17, 2008
- July 23, 2008
- April 28, 2008
- April 17, 2008
- February 29, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
